Literature DB >> 2101721

Metabolic factors in cancer susceptibility.

C R Wolf1.   

Abstract

The majority of cancers appear to arise from gene mutations induced by chemicals in the environment. Although the resulting metabolic changes which confer the tumour phenotype are still poorly defined, considerable progress has been made in identifying the genes responsible. In addition, there have been significant advances in identifying the genes important in determining the sensitivity of cells to tumorigenic agents. Animal studies clearly demonstrate that individual differences in their expression can lead to profound differences in cancer susceptibility. There is a growing body of evidence that polymorphisms in certain of these genes are also involved in cancer susceptibility in man. This article describes the identification and role of specific metabolic pathways in the tumour initiation and how polymorphisms in their function could relate to cancer susceptibility.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2101721

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  10 in total

Review 1.  Chemoprevention: increased potential to bear fruit.

Authors:  C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Exposure to urban and rural air pollution: DNA and protein adducts and effect of glutathione-S-transferase genotype on adduct levels.

Authors:  P S Nielsen; H Okkels; T Sigsgaard; S Kyrtopoulos; H Autrup
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

3.  Some developments on the affected-pedigree-member method of linkage analysis.

Authors:  P J Ward
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

4.  1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression.

Authors:  G Smith; C J Henderson; M G Parker; R White; R G Bars; C R Wolf
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

5.  Caffeine phenotyping of cytochrome P4501A2, N-acetyltransferase, and xanthine oxidase in patients with familial adenomatous polyposis.

Authors:  A D Spigelman; K C Farmer; S Oliver; K P Nugent; P N Bennett; L J Notarianni; P Dobrocky; R K Phillips
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

6.  Comparative cytochrome P450 proteomics in the livers of immunodeficient mice using 18O stable isotope labeling.

Authors:  Catherine S Lane; Yuqin Wang; Richard Betts; William J Griffiths; Laurence H Patterson
Journal:  Mol Cell Proteomics       Date:  2007-02-11       Impact factor: 5.911

7.  Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility: A Meta-Analysis.

Authors:  Haitao Liu; Jinlin Jia; Xuemei Mao; Zhiyong Lin
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 8.  Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.

Authors:  C P Wild; L A Jansen; L Cova; R Montesano
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

9.  Molecular genetic analysis of the cytochrome P450-debrisoquine hydroxylase locus and association with cancer susceptibility.

Authors:  C A Smith; J E Moss; A C Gough; N K Spurr; C R Wolf
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

10.  Regulation of cytochrome P450 gene expression in human colon and breast tumour xenografts.

Authors:  G Smith; D J Harrison; N East; F Rae; H Wolf; C R Wolf
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.